Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warren Fiskus

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Molecular Cancer Therapeutics|May 14, 2011
Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damageKyungsoo Ha, Warren Fiskus, Rekha Rao, et al.
Blood Cancer Journal|March 23, 2021
EVI1 dysregulation: impact on biology and therapy of myeloid malignanciesChristine Birdwell, Warren Fiskus, Tapan M Kadia, et al.
Molecular Cancer Therapeutics|December 19, 2006
Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cellsWarren Fiskus, Michael Pranpat, Maria Balasis, et al.
Cancer Research|June 19, 2008
Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasionYonghua Yang, Rehka Rao, Jie Shen, et al.
Molecular Cancer Therapeutics|March 1, 2013
Dual PI3K/AKT/mTOR inhibitor BEZ235 synergistically enhances the activity of JAK2 inhibitor against cultured and primary human myeloproliferative neoplasm cellsWarren Fiskus, Srdan Verstovsek, Taghi Manshouri, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2013
Acetylated hsp70 and KAP1-mediated Vps34 SUMOylation is required for autophagosome creation in autophagyYonghua Yang, Warren Fiskus, Bao Yong, et al.
Blood|July 2, 2008
HDAC6 inhibition enhances 17-AAG--mediated abrogation of hsp90 chaperone function in human leukemia cellsRekha Rao, Warren Fiskus, Yonghua Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2Purva Bali, Michael Pranpat, Ramona Swaby, et al.
Blood|October 30, 2004
Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3Prince George, Purva Bali, Srinivas Annavarapu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2007
Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-alpha levels and transcriptional activity: a result of hyperacetylation and inhibition of chaperone function of heat shock protein 90Warren Fiskus, Yuan Ren, Alex Mohapatra, et al.
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Molecular Cancer Therapeutics|May 14, 2011
Hsp90 inhibitor-mediated disruption of chaperone association of ATR with hsp90 sensitizes cancer cells to DNA damageKyungsoo Ha, Warren Fiskus, Rekha Rao, et al.
Blood Cancer Journal|March 23, 2021
EVI1 dysregulation: impact on biology and therapy of myeloid malignanciesChristine Birdwell, Warren Fiskus, Tapan M Kadia, et al.
Molecular Cancer Therapeutics|December 19, 2006
Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cellsWarren Fiskus, Michael Pranpat, Maria Balasis, et al.
Cancer Research|June 19, 2008
Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasionYonghua Yang, Rehka Rao, Jie Shen, et al.
Molecular Cancer Therapeutics|March 1, 2013
Dual PI3K/AKT/mTOR inhibitor BEZ235 synergistically enhances the activity of JAK2 inhibitor against cultured and primary human myeloproliferative neoplasm cellsWarren Fiskus, Srdan Verstovsek, Taghi Manshouri, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2013
Acetylated hsp70 and KAP1-mediated Vps34 SUMOylation is required for autophagosome creation in autophagyYonghua Yang, Warren Fiskus, Bao Yong, et al.
Blood|July 2, 2008
HDAC6 inhibition enhances 17-AAG--mediated abrogation of hsp90 chaperone function in human leukemia cellsRekha Rao, Warren Fiskus, Yonghua Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Activity of suberoylanilide hydroxamic Acid against human breast cancer cells with amplification of her-2Purva Bali, Michael Pranpat, Ramona Swaby, et al.
Blood|October 30, 2004
Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3Prince George, Purva Bali, Srinivas Annavarapu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2007
Hydroxamic acid analogue histone deacetylase inhibitors attenuate estrogen receptor-alpha levels and transcriptional activity: a result of hyperacetylation and inhibition of chaperone function of heat shock protein 90Warren Fiskus, Yuan Ren, Alex Mohapatra, et al.
Pageof 10